This site is intended for U.S. Healthcare Professionals only.
Request a Rep
Patients may take SOTYKTU anywhere, at any time
Managing moderate-to-severe plaque psoriasis can get complicated. With SOTYKTU, patients take a once-daily pill. SOTYKTU can be taken anywhere, at any time that fits best within their daily routine.
THE FIRST AND ONLY ONCE-DAILY ORAL TYK2 INHIBITOR WITH1:
NO TESTS ARE REQUIRED FOR TREATMENT INITIATION OTHER THAN TB EVALUATION
(unless patients have known or suspected liver disease*)
DOSE TITRATION OR DOSE ADJUSTMENTS1
KNOWN DRUG-TO-DRUG INTERACTIONS1
Avoid use with live vaccines
CAN BE TAKEN WITH OR WITHOUT FOOD1
*In patients with known or suspected liver disease, evaluate liver enzymes at baseline and thereafter according to routine patient management.
Tablets should be taken whole.
SOTYKTU tablet is not shown at actual size. For illustrative purposes only.
TB=tuberculosis; TYK2=tyrosine kinase 2.
SOTYKTU, SOTYKTU 360 SUPPORT, and SOTYKTU
are trademarks of Bristol-Myers Squibb Company.
© 2023 Bristol-Myers Squibb Company.
Otezla is a registered trademark of Amgen Inc